Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression: a meta-analysis and meta-regression. Masson, W.; Lobo, M.; Siniawski, D.; Molinero, G.; Masson, G.; Huerín, M.; and Nogueira, J., P. Lipids in Health and Disease, 19(1):111, 2020.
Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression: a meta-analysis and meta-regression [link]Website  abstract   bibtex   
Several studies have investigated the association between non-statin lipid-lowering therapy and regression of atherosclerosis. However, these studies were mostly small and their results were not always robust. The objectives were: (1) to define if a dual lipid-lowering therapy (statin + non-statin drugs) is associated with coronary atherosclerosis regression, estimated by intravascular ultrasound (IVUS); (2) to assess the association between dual lipid-lowering-induced changes in low density lipoprotein cholesterol (LDL-C) and non-high-density-lipoprotein cholesterol (non-HDL-C) levels and atherosclerosis regression.
@article{
 title = {Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression: a meta-analysis and meta-regression},
 type = {article},
 year = {2020},
 identifiers = {[object Object]},
 pages = {111},
 volume = {19},
 websites = {https://doi.org/10.1186/s12944-020-01297-5},
 id = {f71ade4f-51c9-3065-9637-9f32efac46ce},
 created = {2020-05-29T11:24:48.630Z},
 file_attached = {false},
 profile_id = {3bb26c79-1cd6-3945-ac65-a972949fa8b1},
 group_id = {2f9515a1-f4bb-3e7d-9747-925ba4576996},
 last_modified = {2020-05-29T11:24:48.699Z},
 read = {false},
 starred = {false},
 authored = {false},
 confirmed = {false},
 hidden = {false},
 source_type = {JOUR},
 private_publication = {false},
 abstract = {Several studies have investigated the association between non-statin lipid-lowering therapy and regression of atherosclerosis. However, these studies were mostly small and their results were not always robust. The objectives were: (1) to define if a dual lipid-lowering therapy (statin + non-statin drugs) is associated with coronary atherosclerosis regression, estimated by intravascular ultrasound (IVUS); (2) to assess the association between dual lipid-lowering-induced changes in low density lipoprotein cholesterol (LDL-C) and non-high-density-lipoprotein cholesterol (non-HDL-C) levels and atherosclerosis regression.},
 bibtype = {article},
 author = {Masson, Walter and Lobo, Martin and Siniawski, Daniel and Molinero, Graciela and Masson, Gerardo and Huerín, Melina and Nogueira, Juan Patricio},
 journal = {Lipids in Health and Disease},
 number = {1}
}
Downloads: 0